EndPoint: Alek Safarian
24 June 2011 | Joanne Payne Scrip Clinical Research
Five questions for Glenmark's Pearce on emerging regulatory grey areas BioNotebook: Two new VC funds and a financing: Venrock, Accelerator, Cold Genesys Lupin CEO eying Europe, active in M&A space Is the world in better shape than it's ever been?
Other Features & Analysis
Medtech VCs: assessing potential return on investment Fees, GMP, clinical trials, PIC/S and more: Moldova shakes things up for entry into EU pharma space INTERVIEW: Through the eyes of Alcon Vision Care's head of R and D Telehealth: overcoming adoption hurdles – the French approach